APS Support UK / X
Jul 2, 2025, 18:38
A Neonatal 1st: Shocking Intracardiac Thrombosis Tied to Maternal aCL Antibodies
APS Support UK recently shared a thought-provoking post on X:
”First reported case of neonatal intracardiac thrombosis linked to transplacental transfer of maternal aCL antibodies. Highlights importance of aPL testing in unusual Neonatal Thrombosis. Case study only; not representative of all OAPS patients.”
To read the case report follow here.
A striking case study has emerged reporting the first documented instance of neonatal intracardiac thrombosis associated with transplacental transfer of maternal anticardiolipin (aCL) antibodies.
This rare presentation underscores the critical need to consider antiphospholipid antibody (aPL) testing in cases of unexplained or atypical neonatal thrombosis.
It is important to note that this remains a single case and should not be generalized to all Obstetric Antiphospholipid Syndrome (OAPS) presentations, however, such reports serve as valuable reminders of the potential consequences of undiagnosed aPL positivity.
To find out more about rare cases in the world of Thrombosis, read Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD